SEC Form 4 · accession 0001209191-19-002787
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin G Lafond
Officer — SVP, Treasurer & CAO
Period of report
Jan 6, 2019
Accepted (ET)
Jan 8, 2019 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 6, 2019 | A | 37,122 | $0.00 | A | 85,555 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $2.24 | Jan 6, 2019 | A | 58,536 | A | — | Jan 6, 2029 | Common Stock | 58,536 | 58,536 | D |
Explanation of responses
- F112,374 shares shall vest on each of 12/31/2019, 12/31/2020 and 12/31/2021.
- F21/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018.